1-2 of 2
Chelsae Dumbauld
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ipilimumab and Radiation in Patients with High-risk Resected or Regionally Advanced Melanoma

April K.S. Salama, Manisha Palta, Christel N. Rushing, M. Angelica Selim, Kristen N. Linney, Brian G. Czito, David S. Yoo, Brent A. Hanks, Georgia M. Beasley, Paul J. Mosca, Chelsae Dumbauld, Katelyn N. Steadman, John S. Yi, Kent J. Weinhold, Douglas S. Tyler, Walter T. Lee, David M. Brizel
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (5): 1287–1295.
https://doi.org/10.1158/1078-0432.CCR-20-2452
Published: 01 March 2021
View article titled, Ipilimumab and Radiation in Patients with High-risk Resected or Regionally Advanced Melanoma
Open the PDF for Ipilimumab and Radiation in Patients with High-risk Resected or Regionally Advanced Melanoma in another window
Includes: Supplementary data
Journal Articles

Immune Activation in Early-Stage Non–Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab

John S. Yi, Neal Ready, Patrick Healy, Chelsae Dumbauld, Robyn Osborne, Mark Berry, Debra Shoemaker, Jeffrey Clarke, Jeffrey Crawford, Betty Tong, David Harpole, Thomas A. D'Amico, Frances McSherry, Frank Dunphy, Shannon J. McCall, Jared D. Christensen, Xiaofei Wang, Kent J. Weinhold
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (24): 7474–7482.
https://doi.org/10.1158/1078-0432.CCR-17-2005
Published: 14 December 2017
View article titled, Immune Activation in Early-Stage Non–Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab
Open the PDF for Immune Activation in Early-Stage Non–Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab in another window
Includes: Supplementary data